Skip to main navigation Skip to search Skip to main content

A Multicenter, Randomized, Double Blind, Placebo Controlled Parallel Group, Pilot Study to Assess the Efficacy and Safety of H.P. Acthar Gel in Subjects With Relapsing-remitting Multiple Sclerosis

Project: Research

Project Details

StatusFinished
Effective start/end date04/13/18 → 04/13/22

Funding

  • Mallinckrodt Incorporated: $20,350.00